Innovations in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies, and Adult Stem Cell Regeneration, 2018 Study - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 17, 2018--The “Innovations in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies, and Adult Stem Cell Regeneration” report has been added to ResearchAndMarkets.com’s offering.
The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across chemotherapy personalization, cell transplantation, multi-drug resistance studies, and adult stem cell regeneration. The corresponding clinical trials scenario related to monoclonal antibody drugs for autoimmune diseases is also depicted.
Key Topics Covered:
1. Recent Advances in Chemotherapy Personalization, Cell Transplants, Multi-drug Resistance Studies and Adult Stem Cell Regeneration
Chemotherapy Genetic Interaction Map for Personalized Treatment
Pancreatic Cell Transplant Capable of Vascularization
Decoding Acinetobacter Baumannii’s Multi-drug Resistance
Adult Stem Cell Regeneration by Fasting
2. Clinical Trial Analysis and Key Contacts
Clinical Trial Analysis of Monoclonal Antibody Drugs for Autoimmune Diseases
For more information about this report visit https://www.researchandmarkets.com/research/dwt685/innovations_in?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181217005322/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Stem Cells
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/17/2018 06:28 AM/DISC: 12/17/2018 06:28 AM